O
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 25 Jan 2024)
What this means for you
Registered since 31 Jan 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86431648
- Registration number
- 5134104
- Mark type
- Design + words
- Filed
- 22 Oct 2014
- Published for opposition
- 21 Apr 2015
- Registered
- 31 Jan 2017
- Attorney of record
- Kristin S. Cornuelle
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services
Owner
- Tesorx Pharma, LLC, Menlo Park, CA, US
- Tesorx Pharma, LLC, Menlo Park, CA, US
- Tesorx Pharma, LLC, Menlo Park, CA, US
Prosecution history
- 31 Jan 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 25 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 25 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Jul 2023 — TEAS SECTION 8 & 15 RECEIVED
- 31 Jan 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 31 Jan 2017 — REGISTERED-PRINCIPAL REGISTER
- 27 Dec 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Dec 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Dec 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Nov 2016 — USE AMENDMENT FILED
- 02 Dec 2016 — SOU EXTENSION 3 GRANTED
- 28 Nov 2016 — SOU EXTENSION 3 FILED
- 28 Nov 2016 — SOU TEAS EXTENSION RECEIVED